Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
Details for Australian Patent Application No. 2005220728 (hide)
International Classifications
Event Publications
12 October 2006 PCT application entered the National Phase
PCT publication WO2005/086661 Priority application(s): WO2005/086661
6 August 2009 Application Accepted
Published as AU-B-2005220728
8 October 2009 Application for Amendment
The nature of the amendment is: Amend the name of the co-inventors to add Wang, Yingcai and Schmitt, Michael J.. Address for service in Australia - Wrays Ground Floor 56 Ord Street West Perth WA 6005
28 January 2010 Amendment Made
The nature of the amendment is: Amend the name of the co-inventors to add Wang, Yingcai and Schmitt, Michael J.
4 February 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005220731-Patient transfer device having inclined upper surface
2005220723-Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser